#VisualAbstract Venetoclax with dose-adjusted EPOCH-R may be a promising combination therapy for aggressive B-cell lymphoma

byKathleen Lau

October 21, 2021

in StudyGraphics

Treatment of patent ductus arteriosus in very low birth weight infants varies between hospitals

RelatedReports

Benefits of high-intensity surveillance following colorectal adenoma removal likely outweigh costs

Chronic Disease

Adenoma detection rate is inversely associated with post-colonoscopy colorectal cancer risk

March 20, 2023

$Proton radiotherapy may be effective for refractory pituitary adenomas$

Chronic Disease

Pituitary microadenomas exhibit slow growth and may require less frequent MRI surveillance

March 18, 2023

Nivolumab may be effective in platinum-resistant ovarian cancer

Gastroenterology

Addition of PD-L1 inhibitor may improve outcomes in neoadjuvant therapy for esophageal cancer

March 15, 2023

Study explores effects of daily iron supplementation in 2- to 5-year-olds

Chronic Disease

Etranacogene dezaparvovec gene therapy reduces bleeding in severe hemophilia B

March 15, 2023

Prescription of antibiotics for acute respiratory infections increasing

Male sex and older age are independently associated with treatment failure after antibiotic treatment of community-acquired pneumonia

#VisualAbstract: Fulvestrant-palbociclib and letrozole-palbociclib are equally effective for HR⁺ advanced breast cancer

#VisualAbstract: Dose-escalated concurrent chemoradiotherapy does not improve survival in locally advanced esophageal cancer

Top 10 TV Shows to Binge Watch During Lockdown

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

#VisualAbstract Venetoclax with dose-adjusted EPOCH-R may be a promising combination therapy for aggressive B-cell lymphoma

Adenoma detection rate is inversely associated with post-colonoscopy colorectal cancer risk

Pituitary microadenomas exhibit slow growth and may require less frequent MRI surveillance

Addition of PD-L1 inhibitor may improve outcomes in neoadjuvant therapy for esophageal cancer

Treatment of patent ductus arteriosus in very low birth weight infants varies between hospitals

Male sex and older age are independently associated with treatment failure after antibiotic treatment of community-acquired pneumonia

RelatedReports

Adenoma detection rate is inversely associated with post-colonoscopy colorectal cancer risk

Pituitary microadenomas exhibit slow growth and may require less frequent MRI surveillance

Addition of PD-L1 inhibitor may improve outcomes in neoadjuvant therapy for esophageal cancer

Etranacogene dezaparvovec gene therapy reduces bleeding in severe hemophilia B

Male sex and older age are independently associated with treatment failure after antibiotic treatment of community-acquired pneumonia

#VisualAbstract: Dose-escalated concurrent chemoradiotherapy does not improve survival in locally advanced esophageal cancer

Top 10 TV Shows to Binge Watch During Lockdown

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

Want more physician-written
medical news?

#VisualAbstract Venetoclax with dose-adjusted EPOCH-R may be a promising combination therapy for aggressive B-cell lymphoma

RELATED REPORTS

Treatment of patent ductus arteriosus in very low birth weight infants varies between hospitals

Male sex and older age are independently associated with treatment failure after antibiotic treatment of community-acquired pneumonia

RelatedReports

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

Want more physician-written medical news?

Want more physician-written
medical news?